AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Senti Biosciences to present at Synthetic Biology: Engineering, Evolution, & Design Conference.
ByAinvest
Tuesday, Jun 24, 2025 8:49 am ET1min read
Senti Biosciences will present at the 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference. Timothy Lu, MD, PhD, Co-Founder and CEO, will present on "Solving the Grand Challenge of Tumor-Specific Therapies with Logic-Gated Cells." The conference is being held in Houston, TX from June 23-26, 2025.
Senti Biosciences, Inc. (Nasdaq: SNTI), a clinical-stage biotechnology company, will present at the 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference in Houston, TX, from June 23-26, 2025. The company's Co-Founder and CEO, Timothy Lu, MD, PhD, will present on "Solving the Grand Challenge of Tumor-Specific Therapies with Logic-Gated Cells" on June 24, 2025, at 1:20 PM CT [1].The SEED Conference, established in 2014, is a premier technical event for synthetic biology professionals, attracting over 5,000 attendees since its inception. The conference serves as a platform for sharing research, networking, and discussing advances in synthetic biology [2].
Senti Bio is developing next-generation cell and gene therapies using its proprietary Gene Circuit platform. The company aims to engineer Gene Circuits into medicines with enhanced precision and control, specifically targeting cancer cells while sparing healthy cells. The company's pipeline includes cell therapies engineered with Gene Circuits to target challenging liquid and solid tumor indications [1].
The presentation by Timothy Lu at the SEED Conference will highlight the potential of logic-gated cells in addressing the grand challenge of tumor-specific therapies. The company's Gene Circuits have shown preclinical success in both NK and T cells, and the company is exploring their potential in other modalities and diseases outside of oncology [1].
The SEED Conference is expected to provide a valuable opportunity for Senti Bio to share its innovative work, network with industry leaders, and gain insights into the latest advancements in synthetic biology [2].
References:
[1] https://www.globenewswire.com/news-release/2025/06/24/3104254/0/en/Senti-Bio-to-Present-at-the-2025-Synthetic-Biology-Engineering-Evolution-Design-SEED-Conference.html
[2] https://www.stocktitan.net/news/SNTI/senti-bio-to-present-at-the-2025-synthetic-biology-engineering-0uosxt1f3o50.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet